Overall, regulating cGMP/PKG and apelin signaling in RGCs and scleral remodeling by inhibiting lncRNA-XR_002792574.1 may be a candidate strategy for preventing myopia progression, which provides a favorable reference value for subsequent exploration and development of gene editing therapeutics for hereditary myopia. This evidence concerns the gene PRKG1 and myopia.